Complete TDDS / Transdermal Patch Manufacturing Solution

Complete TDDS / Transdermal Patch Manufacturing Solution

HUANGHAI provides wet-coating equipment for drug-in-adhesive Transdermal Drug Delivery Systems (TDDS): precision film coating and drying with in-line lamination on the MJ150 series, then slitting, die-cutting and pouch packaging on the MJ180. Slurry preparation is supplied by the customer or a third party. Designed for pharmaceutical R&D and commercial-scale patch production.

What Is a TDDS Manufacturing System?

A Transdermal Drug Delivery System (TDDS) is a medicated adhesive patch that delivers active pharmaceutical ingredients through the skin at a controlled rate. Manufacturing TDDS patches requires precision equipment for:

  • Preparing and homogenizing the drug-loaded adhesive (supplied by the customer or a third party)
  • Coating the matrix onto a release liner at uniform thickness
  • Controlled drying to lock in drug concentration and adhesive properties
  • Die-cutting or slitting into finished patch dimensions

HUANGHAI's TDDS solution is a solvent-based wet-coating platform for drug-in-adhesive patches, from bench-top R&D to commercial-scale production.

Core Manufacturing Modules

1. Adhesive Matrix Preparation (Customer or Third Party)

Mixing and degassing of the drug-loaded adhesive is not a Huanghai-built module. It is supplied by the customer or a third party; Huanghai can source a slurry mixing tank (5 L or 30 L) and include it in the quotation. Huanghai's own equipment starts at coating.


2. Precision Coating & Drying Line

Why It Matters: Coating thickness must be uniform to ±2% across the full web width to ensure dose consistency. Drying profiles affect adhesive peel force and drug crystallization.

Core Equipment: MJ150 and MJ150-L precision coating lines.

Application Scenarios:

  • Matrix-type patches (adhesive = drug carrier)
  • Transdermal patches for sustained 24–72h delivery

Technical Specifications:

  • MJ150-L — Coating width: 250mm | Speed: 0.2–8 m/min | Drying zones: 3 × independently controlled | Film thickness: 0.05–1.5mm
  • MJ150 — Coating width: 130mm | Speed: 0.2–5 m/min | Drying tunnel: 6m | Temp range: up to 120°C
  • Doctor blade or slot-die coating head options
  • Auto tension control + film shortage alert
  • Online thickness scanner (optional)
  • Solvent recovery system for Class II/III solvents (optional)

3. Die-Cutting & Slitting

Why It Matters: Final patch geometry must be precise for packaging and patient application. Clean edge cuts prevent adhesive migration.

Application Scenarios:

  • Standard oval, round, or rectangular patch shapes
  • Custom die-cutting for branded patch designs
  • High-speed slitting for roll-to-pouch packaging integration

Technical Highlights:

  • Slitting, die-cutting and individual pouch packaging on the MJ180; for TDDS it uses an electrostatic transfer unit for the laminated web
  • Quick-change die tooling
  • Compatible with paper/foil/PE backing materials

4. QC & Documentation

  • Batch manufacturing records (BMR) templates
  • IQ/OQ/PQ document templates (on-site validation is executed by the end user)
  • Data logging designed to support 21 CFR Part 11 compliance: audit trail, electronic records, access control
  • Release testing: weight variation, peel adhesion, content uniformity

TDDS vs ODF: Equipment Overlap and Key Differences

HUANGHAI's MJ Pro series can be configured for either ODF (Oral Dissolving Film) or TDDS (Transdermal Patches) on the same platform; the application is decided before the machine is manufactured.

Parameter ODF (Oral Film) TDDS (Transdermal Patch)
Matrix type Hydrophilic polymer (HPMC, PVA) Adhesive (acrylate, silicone)
Substrate Mylar / PET release liner Siliconized release liner + backing film
Film thickness 0.05–0.3 mm 0.1–1.5 mm (adhesive layer)
Drying profile Water evaporation (60–80°C) Solvent evaporation and recovery
Post-coating Cutting into strips Die-cutting into patch shapes
Shared equipment MJ150 / MJ150-L platform (application decided before manufacture)

Typical TDDS Applications

  • Pain Management: Lidocaine, fentanyl, diclofenac patches
  • Hormonal Therapy: Estradiol, testosterone, progesterone patches
  • Smoking Cessation: Nicotine patches (7mg / 14mg / 21mg)
  • CNS / Neurological: Scopolamine (motion sickness), rivastigmine
  • Cardiovascular: Nitroglycerine, clonidine patches
  • Nutraceutical Patches: Vitamin B12, melatonin, CBD

Ready to Build Your TDDS Line?

Whether you're scaling from lab to pilot or building a commercial CDMO facility, our engineers will help you select the right coating width, drying configuration, and cutting solution for your formulation.

Contact us